ESCs self-renew indefinitely while retaining the capacity for multilineage differentiation, and therefore are a valuable tool for research and potential therapeutic applications. Conventional hESC culture conditions include the use of activin A and basic fibroblast growth factor (FGF) and capture pluripotent cells in a 'primed' pluripotent state in which they resemble the postimplantation epiblast 1,2 . Several laboratories have recently developed protocols to capture pluripotent cells in a more primitive or 'naive' state in which they resemble the preimplantation epiblast 3-5 . Naive stem cells offer a useful system for studies of preimplantation development 6,7 and are more efficient than primed stem cells at producing certain specialized cell types, such as primordial germ cells 8 .
their typical dome-shaped morphology ( Supplementary Fig. 1b ). These results show that reduction of the MEKi concentration from 1 μ M to 0.5 μ M preserved undifferentiated colony morphology and OCT4-GFP expression of hESCs cultured in 5i/LAF. We refer to this modified culture condition as modified 5i/LAF (m5i/LAF) in the remainder of the text. We next exposed primed WIBR3 Δ PE OCT4-GFP hESCs to m5i/LAF to determine whether this culture condition also facilitates conversion to a naive state. Treatment of primed hESCs with either 5i/LAF or m5i/LAF for 10 d led to activation of the Δ PE OCT4-GFP reporter in 60.3% and 25.4% of cells, respectively ( Fig. 1b) . Despite the lower efficiency of conversion, we were able to establish stable, naive hESC lines from the m5i/LAF culture condition by serially passaging bulk cultures, which expressed the Δ PE OCT4-GFP reporter homogeneously ( Supplementary Fig. 1c ). We exposed six additional primed hESC lines-UCLA1, -3, -4, -5, -9, and -17 14 ( Supplementary Fig. 1d )-to either 5i/LAF or m5i/LAF before assessing naive colony morphology and marker expression. We were again able to derive naive cell lines from UCLA4 and UCLA5 hESCs by serial bulk passaging in m5i/LAF. However, the establishment of naive hESC lines from UCLA1, -9, and -17 cells in m5i/LAF was less efficient and could be achieved only after picking and expansion of individual colonies from heterogeneous cultures ( Supplementary  Fig. 1d,e ). Of note, UCLA3 hESCs were resistant to conversion to the naive state in m5i/LAF medium, which warrants future investigation. For all other examined cell lines, the generation of stable, naive hESC cultures exhibiting homogeneous colony morphology took approximately five to six passages in either 5i/LAF or m5i/LAF media, as confirmed by uniform expression of the pluripotency markers NANOG and OCT4 and the naive-cell markers KLF4, KLF17, and DPPA3 (STELLA) in two representative hESC lines ( Fig. 1c and Supplementary Fig. 1f ). We found that naive hESC lines downregulated the primed-cell-specific surface marker THY-1 15 and induced the naive-cell-specific surface marker CD75 15 to a similar degree when cultured in either 5i/LAF or m5i/LAF conditions ( Fig. 1d ). Finally, we confirmed the ability of reprimed m5i/LAF hESCs to access all three germ layers by inducing well-differentiated teratomas in mice ( Supplementary Fig. 1g ). We conclude that m5i/ LAF treatment facilitates not only the maintenance of naive hESCs but also the conversion of primed hESCs to a naive state.
To assess whether titrated PD03 also maintains naive hESCs cultured in t2iLGöY, we initially attempted to transfer naive hESCs from 5i/LAF to the t2iLGöY medium 4, 16 , as to our knowledge this had not been reported before. Starting with WIBR3 hESCs stably grown in 5i/LAF (for more than eight passages), we switched the medium to t2iLGöY, which indeed allowed us to maintain naive hESCs for at least four passages without extinguishing the Δ PE OCT4-GFP reporter, reducing expression of naive-cell markers (KLF2, ZFP42 (REX1), DPPA5, KLF4, and TFCP2L1), or causing a loss of self-renewal potential ( Supplementary Fig. 2a,b ). However, reduction of the PD03 concentration from 1 μ M to 0.5 μ M in t2iL-GöY media was insufficient to maintain the pluripotency of transferred hESCs ( Supplementary Fig. 2c ). Consistent with this, H9 hESCs carrying a naive-cell-specific reporter (EOS-C(3+ )-GFP/ puro R ) 4 could not be expanded after naive conversion in t2iLGöY medium supplemented with 0.5 μ M PD03 even when NANOG and KLF2 were exogenously expressed ( Supplementary Fig. 2d ). We also note that only those primed UCLA lines that efficiently converted to a naive state in m5i/LAF ( Supplementary Fig. 1d and data not shown) could be adapted to t2iLGöY medium, which points to cellline-dependent factors that influence the response to MEK inhibition. We conclude that t2iLGöY-cultured hESCs are more sensitive to PD03 concentration than 5i/LAF-cultured hESCs, as they could not be maintained long-term in titrated MEKi despite the expression of exogenous transcription factors.
Alternative MEK inhibitors maintain hESCs in a naive state. We next investigated whether alternative MEK inhibitors are effective in sustaining naive pluripotency in hESCs. Specifically, we tested a panel of nine MEK inhibitors that target MEK1 alone (TAK-733 and cobimetinib), MEK1 and MEK2 together (selumetinib, trametinib, pimasertib, refametinib, binimetinib, and AZD8330), or MEK1 along with BRAF and CRAF (RO5126766). We replaced PD03 in the 5i/LAF condition with one of two different concentrations of these inhibitors (1 μ M and 0.5 μ M) and then monitored expression of the Δ PE OCT4-GFP transgene ( Fig. 2a ). All nine inhibitors maintained GFP expression at levels observed in PD03-treated cells (Fig. 2b ). However, we detected a loss of dome-shaped morphology in cells cultured with trametinib, AZD8330, or selumetinib; we therefore excluded these small molecules from subsequent experiments. To assess whether alternative MEK inhibitors also facilitate conversion to a naive state, we exposed the primed hESC line UCLA4 to 5i/LAF, m5i/LAF, or 4i/LAF supplemented with 1 or 0.5 μ M of TAK-733, refametinib, cobimetinib, pimasertib, or RO526766 ( Supplementary  Fig. 2e ). We obtained homogeneous cell cultures with naive-celllike morphology that could be expanded for multiple passages with all examined MEK inhibitors at a concentration of 1 μ M, although only TAK-733, refametinib, and cobimetinib maintained naive colony morphology at 0.5 μ M ( Supplementary Fig. 2f ). UCLA4 hESCs cultured under these conditions expressed the naive-cell-associated transcription factors KLF4, KLF17, NANOG, and STELLA ( Fig.  2c ). We quantified conversion efficiency by using flow cytometry to monitor the reactivation of Δ PE OCT4-GFP. Replacement of PD03 with TAK-733, refametinib, or cobimetinib did not affect the percentage of GFP + cells obtained by day 8 of conversion ( Fig. 2d ). Moreover, treatment of hESCs with TAK-733 and cobimetinib at a low concentration (0.5 μ M) activated the Δ PE OCT4-GFP reporter to a similar degree as treatment with a high concentration (1 μ M) of PD03 (~40%) ( Fig. 2d ). Finally, we determined the potential of alternative MEK inhibitors as replacements for PD03 during the maintenance of naive hESCs in t2iLGöY. TAK-733, refametinib, and cobimetinib sustained cell proliferation, clonal growth, and pluripotency-gene expression to a similar extent as PD03 in the context of t2iLGöY culture ( Supplementary Fig. 3a-d ). Overall, these results suggest that (i) PD03 can be substituted by other MEK inhibitors in two different naive culture systems, (ii) targeting of MEK1 alone is sufficient to sustain naive pluripotency, and (iii) low concentrations of TAK-733 and cobimetinib endow primed cells with a naive-cellspecific phenotype.
A naive-cell-like transcriptome and proteome in modified 5i/ LAF cultures. We carried out RNA-seq of hESC lines maintained in primed conditions and in six naive conditions: (i) 5i/LAF, (ii) m5i/ LAF, (iii) 4i/LAF plus 0.5 μ M TAK-733, (iv) 4i/LAF plus 0.5 μ M cobimetinib, (v) 4i/LAF plus 0.5 μ M refametinib, and (vi) hESCs transitioned from 5i/LAF to t2iLGöY for three passages. Principal component analysis (PCA) of these samples showed that the major transcriptional changes along principal component 1 (86% total variability) separated all primed cell lines from all naive cell lines, regardless of culture condition ( Fig. 3a and Supplementary Fig. 4a ). Principal component 2 seemed to detect differences in the genetic background of cell lines regardless of MEKi or cell state (i.e., primed versus naive) ( Fig. 3a ). This is consistent with the previous finding that genetic background drives transcriptional variation among different human pluripotent stem cells 17, 18 .
Genes associated with naive pluripotency (KLF4/5/17, TFCP2L1, and DPPA5) were expressed at high levels in all naive cell lines, whereas genes associated with primed pluripotency (ZIC3, THY1, and PODXL) were expressed only in primed hESCs ( Fig. 3b and Supplementary Fig. 4b ). We confirmed the induction of naivestate-specific genes independently by qRT-PCR in UCLA17 hESCs cultured in either 5i/LAF or m5i/LAF conditions ( Supplementary  Fig. 4c ). Of note, UCLA4 naive cells cultured in 4i/LAF and supplemented with TAK-733 expressed slightly higher levels of naive markers compared with levels in UCLA4 cells cultured in 5i/LAF ( Supplementary Fig. 4d ). Reactome pathway enrichment analysis revealed an overrepresentation of MAPK targets among the upregulated genes in the m5i/LAF condition compared with levels in the 5i/LAF condition ( Supplementary Fig. 4e ), consistent with attenuated MAPK suppression in m5i/LAF-cultured cells. Together, these results demonstrate that hESCs cultured in m5i/LAF or with alternative MEK inhibitors had preserved and in some cases boosted transcription patterns characteristic of naive pluripotent cells.
We next carried out a large-scale quantitative proteomics analysis of UCLA4, UCLA9, and WIBR3 hESC lines derived and maintained in primed conditions, 5i/LAF, or m5i/LAF. In addition, we analyzed the proteome of UCLA4 hESCs cultured in t2iLGöY or in 4i/LAF supplemented with 0.5 μ M TAK-733. We quantified > 8,649 proteins with high expression in primed and naive cells ( Supplementary Fig. 5a and Supplementary Table 1 ). We further observed good correlation (Pearson correlation: ~0.56) between RNA and protein expression in our samples, in line with previous studies that used other cell lines 19 ( Supplementary Fig. 5b ). Unsupervised hierarchical clustering of proteome data accurately separated naive from primed samples regardless of culture condition ( Fig. 3c ). In further agreement with the RNA-seq data, naive hESCs upregulated naive-specific proteins, including FGF4 and KLF17, and downregulated proteins associated with the primed state, such as ZIC3 and THY-1 ( Fig. 3d and Supplementary Fig. 5c ). We again observed higher expression of some naive-cell markers (e.g., DNMT3L and DPPA5) in hESCs cultured in the presence of TAK-733 ( Fig. 3d ). Notably, when we compared proteomics data with RNA-seq data, we found that the expression of ~40% of genes that were upregulated at the protein level in either naive or primed conditions did not change at the RNA level, which suggests that a large fraction of genes are regulated posttranscriptionally ( Supplementary Fig. 5d ). These proteins included chromatin regulators, transcription factors, and RNA-binding proteins, including known pluripotency regulators such as SOX2 and MBNL1 ( Supplementary Fig. 5d ,e).
Collectively, these data show that our modification of the naive culture condition had minimal effects on the proteome of naive hESCs.
Modified 5i/LAF maintains HERVK expression, genomic hypomethylation, and X chromosome inactivation state. Our preparation of RNA-seq libraries from ribodepleted RNA allowed us to measure the expression of transposable elements (TEs). Prior research has suggested that TEs permit sensitive discrimination between primed and naive hESCs 7, 20 . TE transcriptional patterns indeed separated primed samples from all of the naive samples ( Supplementary Fig. 6a ). Inspection of TE subclasses in our cell lines further revealed that members of the HERVK family were exclusively induced in the naive state, in agreement with a recent report 7 and in support of the interpretation that our conditions endow hESCs with a bona fide naive state ( Fig. 4a ). hESCs cultured in medium containing 0.5 μ M TAK-733 showed the highest HERVK expression among cells from all tested naive conditions, including 5i/LAF (Fig. 4a ). This finding correlates with higher levels of naive transcription factors in TAK-733-cultured hESCs and suggests that suppression of MEK1 with this small molecule is most effective at inducing 'naive-like' molecular characteristics.
Global DNA hypomethylation is a key epigenetic hallmark of naive pluripotent cells 21, 22 . We used reduced-representation bisulfite sequencing to assess the effect of naive culture conditions on global DNA methylation relative to that in primed hESCs. All examined naive samples exhibited global hypomethylation compared with that of their primed counterparts ( Fig. 4b and Supplementary Fig. 6b ). In agreement, PCA analysis separated primed from naive samples on the basis of 95,239 1-kb tiles ( Supplementary Fig. 6c ) or promoter regions ( Supplementary  Fig. 6d ). We also observed that imprint control regions became demethylated in naive conditions ( Supplementary Fig. 6e ), in agreement with recent reports 7, 15, 23 . We found that naive cells cultured in m5i/LAF had slightly higher global methylation levels compared with those of 5i/LAF cultures, consistent with our previous finding that PD03 drives genomic hypomethylation in naive mouse ESCs 11 . Closer inspection of these regions revealed 984 sites that were specifically hypermethylated in m5i/LAF relative to 5i/LAF cultures ( Supplementary Fig. 6f ). Most of these regions were associated with repetitive DNA elements of the SINE and LINE families ( Supplementary Fig. 6g ). UCLA4 hESCs exposed to 4i/LAF plus 0.5 μ M TAK-733 showed the lowest overall methylation levels among the tested cell cultures, including 5i/LAF cultures ( Fig. 4b and Supplementary Fig. 6b ), which concurs with the relative upregulation of naive-cell-specific markers in TAK-733-treated hESCs (Figs. 3d and 4a and Supplementary Fig. 4d ).
X-chromosome inactivation (XCI) is another tightly regulated epigenetic process that distinguishes primed from naive female hESCs 6, 24 . We used RNA fluorescence in situ hybridization (RNA-FISH) for X-linked transcripts to assess how the m5i/LAF condition influences XCI status. Although all tested female primed hESCs lacked XIST expression because of XCI erosion, we confirmed the presence of two X chromosomes by RNA-FISH for the X-linked gene UTX (KDM6A), which generally escapes XCI ( Fig. 4c and Supplementary Fig. 7a,b ). We detected monoallelic transcription of HUWE1, an X-linked gene commonly subject to XCI, in four of five primed hESC lines (UCLA1, -4, and -5 and WIBR3) ( Fig. 4c and Supplementary Fig. 7a -c). UCLA9 cells showed HUWE1 signal from both X chromosomes, as previously observed for this line ( Supplementary Fig. 7c and ref. 14 ) . Adaptation of all primed hESC lines to either 5i/LAF or m5i/ LAF conditions resulted in biallelic transcription of HUWE1, indicative of X-chromosome reactivation in the naive state ( Fig. 4c and Supplementary Fig. 7a -c). We next sought to quantify XIST signal in primed, 5i/LAF-cultured, and m5i/LAF-cultured hESCs. Colonies in which XIST signal was present or absent in more than 80% of cells were considered XIST + and XIST -, respectively. Colonies with heterogeneous patterns of XIST expression were designated as XIST +/− . The vast majority (~95%) of naive colonies that we derived and expanded in regular 5i/LAF media expressed XIST from one of the active X chromosomes (XIST + ), in agreement with a previous report 6 . Naive cells cultured in m5i/LAF showed a lower fraction (20-40%) of XIST + colonies ( Fig. 4d ). Collectively, these results indicate that the m5i/LAF culture condition captures a bona fide naive state that extends from the gene expression and proteomic level to the level of TE transcription and epigenetic modification.
Modified 5i/LAF condition preserves hESC genomic stability.
We examined the functional consequences of continual treatment of naive hESCs with titrated PD03 by measuring growth potential, apoptosis, and genomic stability. hESC lines cultured in m5i/LAF proliferated more rapidly than hESCs cultured in 5i/LAF (n = 3 representative hESC lines), indicating that strong MAPK inhibition limits the growth potential of naive hESCs (Fig. 5a ). These differences in growth behavior were more pronounced in some hESC lines (e.g., UCLA5; approximately fourfold) than in others (e.g., UCLA4; approximately twofold), which pointed once more to cell-line-intrinsic responses to MAPK modulation. We found that m5i/LAF-cultured WIBR3 hESCs gave rise to twice as many colonies as 5i/LAF-cultured hESCs in a clonal colony formation assay, suggesting increased viability of dissociated hESCs that were maintained with low concentrations of MEKi ( Supplementary  Fig. 8a ). Consistent with these observations, we detected a twofold decrease in the fraction of annexin V + cells among m5i/LAFcultured WIBR3 hESCs compared with that in 5iLAF cultures ( Supplementary Fig. 8b ). hESCs cultured in t2iLGöY and subsequently plated in reduced concentrations of PD03 (0.6 μ M) for 7 d also exhibited higher clonogenic potential ( Supplementary Fig. 8c ). Together, these results show that the use of reduced concentrations of MEKi in two naive culture conditions led to increased proliferation and decreased apoptosis.
Recent studies have shown that suppression of MAPK/ERK signaling compromises genomic stability in mouse ESCs 25 and   POU5F1  EPCAM  SALL4  ZIC2  ZIC3  PODXL  THY1  DNMT3B  KLF4  KLF5  KLF17  DPPA3  DPPA5  GDF3  DNMT3L  TFCP2L1  ZFP57   4   6   8   10   12 14 PC1: 86% variance PC2: 3% variance PCA analysis (top 500 genes) Samples (P10) that this is accompanied by an increased number of γ -H2AX foci, which correlate with DNA double-strand breaks 26 . We used flow cytometry to examine the frequency of γ -H2AX foci in primed hESCs and naive hESCs cultured in either 5i/LAF or m5i/LAF. hESCs expanded in 5i/LAF showed a fourfold increase in the number of γ -H2AX foci (~20%) compared with that in hESCs maintained in primed conditions (~5%) (Fig. 5b ). Decreasing the amount of PD03 from 1 μ M to 0.5 μ M reduced the percentage of γ -H2AX foci (~10%; P = 0.0005), thus supporting the interpretation that strong MAPK inhibition via PD03 triggers a DNA damage response.
On the basis of our observations, we hypothesized that naive hESCs in m5i/LAF might retain a relatively normal karyotype owing to reduced selective pressure. Indeed, we found that naive WIBR3 hESCs cultured in m5i/LAF for ten passages retained a largely normal karyotype that was similar to that of the parental hESCs cultured in primed medium ( Fig. 5c and Supplementary  Fig. 8d,e ). By contrast, hESCs cultured in conventional 5i/LAF media for the same period of time acquired multiple additional chromosomal abnormalities, and none of the karyotyped cells (n = 20) were normal ( Supplementary Fig. 8f) .
To test the generality of our findings, we carried out shallow whole-genome sequencing of UCLA1, -4, -5, and -17 hESCs after continual propagation of these cell lines for ten passages in primed media, 5i/LAF, m5i/LAF, and 4i/LAF supplemented with TAK-733. We found that UCLA5 hESCs cultured in 5i/LAF conditions accrued a greater number of chromosomal aberrations (trisomy 5; partial amplification of chromosome 7; loss of one X chromosome; and partial loss of chromosomes 8, 9, and 15) compared with cells cultured in the m5i/LAF conditions (trisomy 5 and partial amplification of chromosome 7) ( Fig. 5d) . Similarly, UCLA1 and UCLA17 hESCs cultured in 5i/LAF showed trisomy 5 and 7, whereas they remained mostly normal in m5i/LAF conditions ( Fig. 5d and Supplementary Fig. 8g ). Naive hESCs cultured in 4i/ LAF and TAK-733, which showed higher HERVK transcription, increased RNA and protein expression of naive-cell markers, and reduced global methylation compared with hESCs in the other MEKi conditions, became highly abnormal after ten passages (trisomy 7, 12, and 13) ( Fig. 5d ). These results imply that reduced MAPK inhibition relieves selection pressure for the acquisition of chromosomal abnormalities that promote the growth and/or survival of naive hESCs. 
Molecular effects of reduced MEK inhibition.
In an effort to understand the mechanisms by which increased MEK activity affects naive hESC properties, we generated phosphoproteomic data for UCLA4 hESCs cultured in 5i/LAF, m5iLAF, and t2iLGöY (Supplementary Table 2 ). We confirmed that reduction of the PD03 concentration to 0.5 μ M resulted in increased ERK phosphorylation in UCLA4 hESCs, which we verified independently by western blot analysis ( Supplementary Figs. 9a,b and 10 ). We also observed increased phosphorylation of other components of the MAPK pathway ( Fig. 5e ). We next focused on proteins that gained phosphorylation (> 1.5-fold) in m5i/LAF relative to 5i/LAF culture conditions but were not directly related to MAPK signaling. Most of these proteins were associated with functional categories related to "DNA repair, " "DNA methylation, " "DNA damage checkpoints, " and "G1/S transition of cell cycle, " which implies that MAPK inhibition by PD03 affects molecular regulators of genomic stability and DNA repair (Fig. 5f ). We confirmed overrepresentation of these functional categories by using an independent hESC line (UCLA9) ( Supplementary  Fig. 9c,d ). Finally, we selected proteins with differential phosphorylation between hESCs cultured in 5i/LAF and hESCs cultured in t2iLGöY and carried out Gene Ontology enrichment analysis. Surprisingly, we also observed a clear enrichment of categories related to the MAPK pathway. Considering that equal concentrations of PD03 are present in 5i/LAF and t2iLGöY, this observation points to MEKi-independent modulation of the MAPK pathway in one of the two naive culture conditions ( Supplementary Fig. 9e ).
Discussion
Through systematic characterization of primed and naive hESCs maintained under different culture conditions, we uncovered an unexpected sensitivity of naive pluripotent stem cells to MAPK signal inhibition, which affects their proliferation rate, survival, and genome integrity. We propose that minimal MAPK activity is beneficial for the preservation of both robust growth potential and genomic stability in naive human pluripotent stem cells maintained in 5i/LAF (model in Supplementary Fig. 9f ). Our data also suggest that different hESC lines respond differently to MEK inhibition. For instance, we found that the concentration of PD03 could be reduced to 0.5 μ M in WIBR3 hESCs and to 0.25 μ M in UCLA4 hESCs without adverse effects (data not shown). We suggest that MEK inhibitors should ideally be titrated in a cell-line-dependent fashion. The observation that attenuated MEK inhibition affects the phosphorylation levels of proteins that regulate DNA damage and repair and leads to a reduced number of γ -H2AX foci provides a possible molecular explanation for the observed phenotypes.
Our finding that naive hESCs cultured in 5i/LAF and t2iLGöY exhibited differences in MAPK activity despite equivalent concentrations of MEKi suggests that the BRAF and SRC inhibitors in 5i/LAF media further dampen the MAPK pathway compared with t2iLGöY media. The notion that MAPK signaling is less repressed in t2iL-GöY-cultured hESCs than in 5i/LAF-cultured hESCs parallels our observations in m5i/LAF-cultured hESCs and is consistent with the following. First, t2iLGöY-cultured cells, like m5i/LAF-cultured cells, divide more rapidly and are karyotypically more stable than 5i/LAFcultured hESCs 10, 27 . Second, we found that we could not reduce the concentration of PD03 to 0.5 μ M in hESCs continually cultured in t2iLGöY without inducing differentiation ( Supplementary Fig. 2c,d) . Third, UCLA lines that are refractory to naive conversion with bulk passaging in 0.5 μ M PD03 could not be transferred from 5i/LAF to t2iLGöY, which suggests a requirement for stronger suppression of the MAPK pathway in certain hESC lines. Fourth, the majority of cells cultured in t2iLGöY media have two active X chromosomes but lack XIST transcription 6,10 , similar to cells expanded in m5i/LAF medium. Finally, hESCs maintained in t2iLGöY had levels of global methylation that were higher than those in naive cells expanded in 5i/LAF medium but similar to those in m5i/LAF-cultured hESCs (Fig. 4b, Supplementary Fig. 6b, and ref. 27 ).
The transcriptional, proteomic, phosphoproteomic, and genomic methylation data we have generated here will provide a useful resource for future studies aimed at dissecting the mechanisms underlying naive and primed pluripotency. Our results may also have a bearing on potential therapeutic applications of naive pluripotent stem cells, as chromosomal stability is of the utmost importance in cell and gene therapy applications.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41592-018-0104-1. RNA-FISH and microscopy. RNA-FISH was performed as previously described 6 .
Briefly, cells grown on gelatinized glass coverslips were fixed with 4% formaldehyde, permeabilized with 0.5% Triton X-100 (10 min each), and serially dehydrated with 70-100% ethanol. Coverslips were hybridized with labeled DNA probes generated from bacterial artificial chromosomes. We used an Imager M1 microscope (Zeiss) for acquisition and ImageJ software (NIH) for processing of z-stack images.
Western blot analysis. In preparation for western blot analysis, cells were lysed in modified RIPA buffer (50 mM Tris-HCl, pH 8 (Sigma-Aldrich), 150 mM NaCl (Sigma-Aldrich), 0.1% SDS (Sigma-Aldrich), 0.5% sodium deoxycholate (Sigma-Aldrich), 1% Triton X-100 (Sigma-Aldrich), 1 mM EDTA (Sigma-Aldrich), 1× protease inhibitor cocktail (Roche Diagnostics), 1× PhosSTOP phosphatase inhibitors (Roche Diagnostics), and 0.01 U/µ l benzonase (Novagen)). Lysates were sonicated for 5 min with a Bioruptor sonication device (Diginode Diagnostics).
The following antibodies were used for western blotting: β -actin (Cell Signaling Technology; clone 13E5; 5125), ERK1/2 (Cell Signaling Technology; 137F5; 4695), and p-ERK1/2 (Cell Signaling Technology; D13.14.4E; 4370).
Alkaline phosphatase staining. Alkaline phosphatase staining was performed with the Vector Red substrate kit (Vector Labs). Colony quantifications were performed using ImageJ.
RNA preparation. RNA was isolated with the miRNeasy mini kit (Qiagen). RNA was eluted from the columns with RNase-free water and quantified on a Nanodrop ND-1000. cDNA was produced with the High Capacity RNA-to-cDNA kit (Applied Biosystems). To generate material for sequencing, we sorted cells for cell viability (DAPI staining). Reduced-representation bisulfite sequencing. Reduced-representation bisulfite sequencing (RRBS) libraries were prepared with a commercial kit (Ovation RRBS Methyl-Seq System; NuGen, San Carlos, CA) according to the manufacturer's protocol, except that we pooled 12 individually barcoded reactions after the final repair step and carried out bisulfite conversion and library amplification using that pool. Libraries were sequenced on an Illumina HiSeq 2500 high-output flow cell without a PhiX spike-in using Nugen's custom sequencing primer for read 1 (50 bases) and standard Illumina sequencing primers to read the 8-base sample barcodes. Sequencing reads were trimmed with Trim Galore! (default parameters; http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/) and a NuGENprovided script for diversity trimming and filtering. Trimmed reads were aligned to the hg19 human genome using BSmap 29 with flags -v 0.05 -s 16 -w 100 -S 1 -p 8 -u. The methylation status of CpGs was called by observation of bisulfite conversion in reads at locations of cytosines in the reference sequence. Region methylation averages were called using CpGs that were covered with at least three reads in at least 80% of samples. Imprinting control regions were defined as in ref. 30 .
FACS analyses.
We analyzed levels of GFP, annexin V (allophycocyanin; BD Bioscience; 550474), γ -H2AX (Alexa Fluor 647; BD Bioscience; 560447), THY-1 (phycoerythrin; anti-human CD90 (Biolegend; 328110)), and CD75 (purified antihuman CD75 (LN-1; 326901; Biolegend)) with a BD LSR II FACS (BD Biosciences) using Diva v6.1.2 (BD Biosciences) and FlowJo software v10 (TreeStar). Cell permeabilization was carried out with the Fix and Perm Cell fixation and cell permeabilization kit (Thermo Fisher Scientific; GAS003) according to the manufacturer's instructions. We used goat anti-mouse IgM heavy chain secondary antibody, Alexa Fluor 647 conjugate (1:500) (A-21238; Thermo Fisher), as a secondary antibody.
Immunofluorescence. For immunostaining, the cells were fixed with 4% paraformaldehyde, blocked, and incubated with primary antibodies overnight at 4 °C. They were then stained with secondary antibodies goat anti-rabbit IgG (H + L) (1:500) (Alexa Fluor 488; A11008; Thermo Fisher) and goat antimouse IgG (H + L) (1:500) (Alexa Fluor 546; A11003; Thermo Fisher) at room temperature for 1 h. Nuclei were stained with DAPI (1:1,000; BD Bioscience; 564907). The following primary antibodies were used in this study: anti-KLF17 produced in rabbit (1:100; HPA024629; Sigma), GKLF/EKLF/LKLF antibody (F-8; 1:100; sc-166238; Santa Cruz), mouse anti-Stella (1:100; MAB4388; EMD Millipore), Nanog (D73G4) XP rabbit (mAb 4903; 1:300; 4903 S; Cell Signaling), and Oct-3/4 antibody (C-10; 1:300; sc-5279; Santa Cruz).
Teratoma assay. 2 × 10 6 cells were resuspended in 300 μ l of Matrigel (Corning) and injected subcutaneously into the flanks of an immunocompromised NOD/ SCID mouse. Teratomas were monitored and removed once tumor size reached 1 cm or tumors became ulcerated. Tumors were then weighed and processed for hematoxylin and eosin staining analysis. The tumor sections were blindly scored for the presence of each germ layer. Human naive cells were re-primed in hES primed media and cultured as primed cells before injection.
Chromosomal integrity analysis by shallow-coverage whole-genome resequencing. Chromosomal aneuploidy and partial amplification/deletion were examined by shallow-coverage whole-genome resequencing as described in our previous study, with modifications 11 . Briefly, genomic DNA (1.1 µ g in 55 µ L) was sonicated with a Covaris S2 sonicator (Covaris, Woburn, MA) to ~350-bp peak fragments and subjected to PCR-free synthesis of Illumina NextSeq deep sequencing libraries using the TruSeq DNA PCR-free LT sample preparation kit, set A (Illumina; FC-121-3001) according to the protocol provided by the manufacturer (Illumina FC-121-9006DOC, part 15036187 Rev. D). During the library synthesis, we used the adaptor without index sequences from NEBNext Multiplex Oligos for Illumina Dual Index Primer Set 1 (7600S; New England Biolabs, Ipswich, MA), and the loops of the adaptor ends were cut with the USER enzyme provided in the kit. The index-free libraries were amplified with adaptors including the i7 and i5 dual-index sequences for 12 cycles and quantified with a KAPA Illumina library quantification qPCR kit (KAPA Biosystems, Wilmington, MA), and equal concentrations (4 nM) of libraries were pooled. Size distributions of gDNA fragments and deep-sequencing libraries were examined with Agilent Tapestation with Genomic DNA screening tapes (Agilent Technologies, Santa Clara, CA) and passed our standard quality-control criteria. Single-read deep sequencing (76 nt) was carried out on an Illumina NextSeq 500 sequencer with the high output v2 kit, and the machine-generated base call (bcl) files were converted to raw read sequence files (fastq) using the Illumina bcl2fastq tool (2.17.1.14) . Fastq files were subjected to a quality-control process using Trim Galore! and fastQC (Babraham Institute, Cambridge, UK), which excluded raw quality reads (Phred score < 20) and deleted the Illumina adaptor sequences and the last nucleotide at the 3′ end to avoid nucleotide base biases. The trimmed/ quality-controlled fastq reads were aligned to the mouse GRCm38/mm10 reference genome sequence using the STAR aligner (ver. 2.4.2.a) with the genomic DNA alignment configuration, thus generating the BAM format aligned read files. The BAM files generated from the four lanes of the sequencer were sorted, merged, and subjected to uniquely mapped read extraction using the sambamba toolkit 31 35 . TEs that overlapped exons were discarded. TEs that did not have at least one sample with 20 reads and genes that did not have at least one sample with 5 reads were removed from all downstream analysis. Count normalization was done with size factors to correct for differences in sequencing depth and was followed by variance stabilizing transformation scaling and differential expression analysis by DESeq2 36 . A gene (or TE) was considered to be differentially expressed when abs(log 2 (fold change)) > 3 and false discovery rate (FDR) < 0.01. Statistically significant (P < 0.01) proteins for primed and naive conditions were determined by paired t-test, and Pearson correlation was used as a metric to compare differential fold changes between genes and proteins. R studio (https://www.rstudio.com/) was used to run custom R scripts for PCA, hierarchical clustering (stats package) and variance analysis, and to construct heat maps (pheatmap package), scatter plots, violin plots, and dendrograms. Generally, the ggplot2 package was used to visualize data graphs. Gene Ontology analysis was done with EnrichR.
Proteomics and phosphoproteomics. Cells were syringe-lysed in a buffer containing 2% SDS, 150 mM NaCl, 50 mM Tris, pH 8.5, 2 mM sodium vanadate, and protease and phosphatase inhibitors. Protein concentrations in the clarified lysates were estimated via bicinchoninic acid (BCA) protein assay (Thermo Fisher Scientific). Lysates were reduced with 5 mM DTT for 30 min at 60 °C. After cooling to room temperature, cysteine residues were alkylated with 14 mM iodoacetamide in the dark for 45 min at room temperature. Liquid chromatography and tandem mass spectrometry. All mass spectra were collected on an Orbitrap Fusion Lumos mass spectrometer (Thermo Fisher Scientific) equipped with a Proxeon EASY-nLC 1000 liquid chromatography system (Thermo Fisher Scientific). Peptides and phosphopeptides were separated on a 75-μ m-inner-diameter microcapillary column packed with ~35 cm of Sepax GPC18 resin (1.8 μ m, 150 Å; Thermo Fisher Scientific). Approximately 2 μ g of peptides and 2.5 μ g of phosphopeptides were separated via 3-h and 2-h gradients, respectively, of acidic acetonitrile. We used the multinotch MS3-based TMT method 37 . The proteome-wide analysis (12 fractions) and phosphoproteome-wide analysis (24 fractions) scan sequences began with a full MS spectrum (MS1) acquired in the Orbitrap (resolution, 120,000; mass range, 400− 1,400 Th) followed by up to 10 MS/ MS spectra (MS2). MS2 settings included collision-induced dissociation (collision energy: 35) with a maximum ion injection time of either 50 ms (proteome) or 200 ms (phosphoproteome) and an isolation window of 0.5 Da. For quantitative information, MS3 precursors were fragmented by high-energy collision-induced dissociation (collision energy: 55) and analyzed in the Orbitrap (resolution of 50,000 at 200 Th) with a maximum ion injection time of either 110 ms (proteome) or 300 ms (phosphoproteome) and an isolation window of 1.2 38 .
Mass spectrometry data analysis. Mass spectra were processed via a SEQUESTbased software pipeline 39 . A modified version of ReAdW.exe was used to convert spectra to mzXML. All spectra were searched against a database containing the human proteome downloaded from UniProt in both forward and reverse orientations and common contaminant protein sequences. Database searches were performed with a peptide mass tolerance of 20 p.p.m. and a fragment ion tolerance of 0.9 Da. These wide mass-tolerance windows were chosen to maximize sensitivity in conjunction with SEQUEST searches and linear discriminant analysis 39, 40 . TMTs on lysine residues and peptide N termini (+ 229.163 Da) and carbamidomethylation of cysteine residues (+ 57.021 Da) were set as static modifications, and oxidation of methionine residues (+ 15.995 Da) was set as a variable modification. Phosphoproteome fractions also included variable modifications of phosphorylation on serine, threonine, and tyrosine residues (+ 79.966 Da).
Peptide-spectrum matches were filtered by linear discriminant analysis to an FDR of 1% at the peptide level on the basis of matches to reversed sequences, as described previously 40 . Linear discriminant analysis considered the following parameters: cross-correlation, Δ C n , missed cleavages, adjusted p.p.m., peptide length, fraction of ions matched, charge state, and precursor mass accuracy. We considered only peptides containing phosphorylation modifications when setting the FDR for phosphopeptides. Filtered peptides were collapsed further to a final protein-level FDR of 1%. We quantified peptides from MS3 scans after filtering out those with poor quality (required total TMT reporter signal-to-noise ratio > 200 and isolation specificity of 0.5). Localization of phosphorylation sites was determined by AScore, and sites with an AScore > 13 were selected for further analysis. For protein quantitation, the signal-to-noise values for all peptides for a given protein were summed, and each TMT channel was summed across all quantified proteins and normalized to enforce equal protein loading. Prior to downstream analysis, relative protein measurements across the 11 samples were normalized to sum to 100. Hierarchical clustering was performed in R on Euclidean distances via the ward.D2 method. Corresponding author(s): Konrad Hochedlinger
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